Frelii, Inc. (OTC: FRLI) Developing personalized medicine using DNA big data & AI

July 9, 2019 admin CEO Interview, Healthcare Comments Off on Frelii, Inc. (OTC: FRLI) Developing personalized medicine using DNA big data & AI

 

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

Ian Jenkins, CEO

 

 

 

 

 

 

 

Frelii, Inc. (OTC: FRLI), interview with CEO Ian Jenkins discussing the company’s personalized medicine technology which uses human DNA gene sequencing and artificial intelligence (AI) to assess more than 3.2 billion markers on the human genome.

 Ian explains how Frelii is starting to commercialize it’s technology with initial applications in medical cannabis, and psychotropic medicines. 

 

 




Related Articles

CEO Interview

James E. Wagner Cultivation Corp. (TSX.V: JWCA) (OTC: JWCAF) Aeroponic cannabis grower expanding capacity

April 4, 2019 admin CEO Interview, Consumer Comments Off on James E. Wagner Cultivation Corp. (TSX.V: JWCA) (OTC: JWCAF) Aeroponic cannabis grower expanding capacity

  Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]

Newsmakers

FSD Pharma Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer

November 26, 2018 admin Newsmakers Comments Off on FSD Pharma Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer

Management addition comes as FSD accelerates specialty cannabinoid pharmaceutical global expansion strategy TORONTO, Nov. 26, 2018 – FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today the appointment of […]